Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Arceci

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Journal of Pediatric Hematology/Oncology|October 7, 2003
The challenge and cost of patient safetyRobert J Arceci
Journal of Pediatric Hematology/Oncology|March 21, 2002
Down syndrome, transient myeloproliferative syndrome, and leukemia: bridging development and neoplasiaRobert J Arceci
Pediatric Blood & Cancer|December 2, 2005
Surviving childhood cancer: a special series on the successes and challenges after "cure"Robert J Arceci
Journal of Pediatric Hematology/Oncology|September 10, 2002
Comments From the Editor-in-ChiefRobert J Arceci
Current Opinion in Hematology|June 10, 2008
When T cells and macrophages do not talk: the hemophagocytic syndromesRobert J Arceci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Dendritic cell disorders: matters of lineage and clinical drug testing in rare diseasesRobert J Arceci
Journal of Pediatric Hematology/Oncology|April 8, 2003
Robbing Peter to pay Paul? Financial reimbursement for chemotherapyRobert J Arceci
Pediatric Blood & Cancer|September 11, 2008
Pediatric Blood & Cancer: the first 5 yearsRobert J Arceci
Pediatric Blood & Cancer|May 6, 2004
The challenges of cancer survivorshipRobert J Arceci
Current Opinion in Hematology|June 4, 2002
Progress and controversies in the treatment of pediatric acute myelogenous leukemiaRobert J Arceci
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Journal of Pediatric Hematology/Oncology|October 7, 2003
The challenge and cost of patient safetyRobert J Arceci
Journal of Pediatric Hematology/Oncology|March 21, 2002
Down syndrome, transient myeloproliferative syndrome, and leukemia: bridging development and neoplasiaRobert J Arceci
Pediatric Blood & Cancer|December 2, 2005
Surviving childhood cancer: a special series on the successes and challenges after "cure"Robert J Arceci
Journal of Pediatric Hematology/Oncology|September 10, 2002
Comments From the Editor-in-ChiefRobert J Arceci
Current Opinion in Hematology|June 10, 2008
When T cells and macrophages do not talk: the hemophagocytic syndromesRobert J Arceci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Dendritic cell disorders: matters of lineage and clinical drug testing in rare diseasesRobert J Arceci
Journal of Pediatric Hematology/Oncology|April 8, 2003
Robbing Peter to pay Paul? Financial reimbursement for chemotherapyRobert J Arceci
Pediatric Blood & Cancer|September 11, 2008
Pediatric Blood & Cancer: the first 5 yearsRobert J Arceci
Pediatric Blood & Cancer|May 6, 2004
The challenges of cancer survivorshipRobert J Arceci
Current Opinion in Hematology|June 4, 2002
Progress and controversies in the treatment of pediatric acute myelogenous leukemiaRobert J Arceci
Pageof 12